Td Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Td Asset Management Inc
- $102 Billion
- Q1 2025
A detailed history of Td Asset Management Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 56,606 shares of ARWR stock, worth $931,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,606
Previous 63,784
11.25%
Holding current value
$931,734
Previous $1.2 Million
39.87%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$217 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$183 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$115 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$86.1 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.74B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...